Unicycive resubmitted its oxylanthanum carbonate NDA to the FDA with CMC data from a compliant new vendor, anticipating an FDA acceptance within 30 days and a new PDUFA target date six months from now.
Unicycive resubmitted its oxylanthanum carbonate NDA to the FDA with CMC data from a compliant new vendor, anticipating an FDA acceptance within 30 days and a new PDUFA target date six months from now.